您的位置: 首页 > 农业专利 > 详情页

Use of Deferiprone and Methods to Treat and/or Prevent Friedreich Ataxia Resulting from Intracellular Mishandling of Iron
专利权人:
Ioav Cabantchik;Michael Spino;Arnold Munnich
发明人:
Arnold Munnich,Michael Spino,Ioav Cabantchik
申请号:
US13755048
公开号:
US20130190365A1
申请日:
2013.01.31
申请国别(地区):
US
年份:
2013
代理人:
摘要:
A therapeutically effective amount of deferiprone or deferasirox or physiologically acceptable salts thereof for the prevention, stabilization, treatment, or reversal of iron-induced FRDA disease in patients resulting from mitochondrial iron-induced damage to preferentially reduce the iron stores in the mitochondria. Also for the treatment of other conditions affecting the brain where a key element in the generation of the resultant pathology is the intracellular mishandling of iron.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充